| narco | narcotic, narcotic addict, drug enforcement agent |
|---|---|
| NA | 1) Narcotic Anonymous 2) Nomina Anatomica; Anatomic Nomenclature; 해부학 명명법... |
| NARC | narcotic; National Association for Retarded Children; nucleus arcuatus |
| NDSB | Narcotic Drugs Supervisory Board |
| NNAS | neonatal narcotic abstinence syndrome |
| dermopathy | Any disease of the skin. Synonymous with dermatopathy. (12 Dec 1998) |
|---|---|
| diabetic dermopathy | Small macules and papules of the extensor surfaces of the extremities, most commonly the shins of diabetics, which become atrophic, hyperpigmented, and occasionally undergo ulceration with scarring; may be a manifestation of microangiopathy. (05 Mar 2000) |
| analgesics, non-narcotic | Drugs that have principally analgesic, antipyretic, and anti-inflammatory actions. They do not bind to opioid receptors and are not classified under the controlled substances act. (12 Dec 1998) |
| narcotic | 1. Pertaining to or producing narcosis. 2. <pharmacology> An agent that produces insensibility or stupor, applied especially to the opioids, i.e. To any natural or synthetic drug that has morphine like actions. Origin: Gr. Narkotikos = benumbing, deadening (18 Nov 1997) |
| narcotic analgesic agent | <pharmacology> Medications that relieve pain but have addictive potential if used regularly. Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin. (27 Sep 1997) |
| narcotic analgesics | <pharmacology> Medications that relieve pain but have addictive potential if used regularly. Examples include: meperidine, morphine, propoxyphene, codeine, hydrocodone, oxycodone, hydromorphone, nalbuphine, butorphanol and heroin. (27 Sep 1997) |
| narcotic antagonists | Agents inhibiting the effect of narcotics on the central nervous system. (12 Dec 1998) |
| narcotic blockade | The use of drugs to inhibit the effects of narcotic substances, as with naloxone. (05 Mar 2000) |
| narcotic hunger | The physiological craving for narcotics. (05 Mar 2000) |
| narcotic reversal | The use of narcotic antagonists, such as naloxone, to terminate the action of narcotics. (05 Mar 2000) |
| drug and narcotic control | Control of drug and narcotic use by international agreement, or by institutional systems for handling prescribed drugs. This includes regulations concerned with the manufacturing, dispensing, approval (drug approval), and marketing of drugs. (12 Dec 1998) |
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|
제품명 |
판매사 |
보험코드 | 성분/함량 | 구분/보험급여 |
|---|